|
DSpace at RU >
University Library >
Academic bibliography >
|
| Title: | EUCAST technical note on posaconazole |
| Author(s): | Arendrup, M.C.
Cuenca-Estrella, M.
Donnelly, J.P. (107876701)
Hope, W.
Lass-Florl, C.
Rodriguez-Tudela, J.L. |
| Publication year: | 2011 |
| Document type: | Article / Letter to editor |
| Journal: | Clinical Microbiology and Infection |
| ISSN: | 1198-743X |
| Volume: | vol. 17 |
| Issue: | iss. 11 |
| Start page: | p. E16 |
| End page: | p. 7 |
| Annotation: | Arendrup, M C Cuenca-Estrella, M Donnelly, J P Hope, W Lass-Florl, C Rodriguez-Tudela, J-L European committee on antimicrobial susceptibility testing - subcommittee on antifungal susceptibility testing (EUCAST-AFST) France Clin Microbiol Infect. 2011 Nov;17(11):E16-7. doi: 10.1111/j.1469-0691.2011.03646.x. Epub 2011 Sep 16. |
| Abstract: | The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for posaconazole for Candida spp. This Technical Note is based on the EUCAST posaconazole rationale document (available on the EUCAST website: http://www.eucast.org). Species-specific breakpoints for C. albicans, C. parapsilosis and C. tropicalis are S: MIC </=0.06 mg/L, R: MIC >0.06 mg/L. There are insufficient data to set breakpoints for C. glabrata and C. krusei as well as non-species-related breakpoints. The breakpoints are based upon pharmacokinetic data, epidemiological cut-off values and clinical experience. Breakpoints will be reviewed regularly. |
| Subject: | N4i 2: Invasive mycoses and compromised host
ONCOL 3: Translational research |
| Organization: | UMCN Extern
Haematology |
| Appears in Collections: | Academic bibliography
|
|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2066/97845
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
|
